Lilly to acquire AtaiBeckley and expand depression pipeline
Lilly plans to acquire AtaiBeckley, adding clinical neuroplastogen programs for treatment-resistant depression to its neuroscience pipeline.
Image: Eli Lilly and Company
Novartis, Klinikum Bayreuth and myon.clinic launch digital RLT network
Novartis, Klinikum Bayreuth and myon.clinic are piloting a digital patient pathway for radioligand therapy in prostate cancer care.
Schwabe takes majority stake in Hydraid
Schwabe Group takes a majority stake in Hydraid, strengthening its position in natural health solutions and functional sports hydration.
COMPRIX advisory board appoints Christoph Bohlender
Christoph Bohlender of MENSCH Kreativagentur joins the COMPRIX advisory board as Dr. Giuseppe Gianni of Brand Health steps down.
STADA Health Report: Most Europeans are open to AI in healthcare
STADA’s Health Report 2026 finds broad European openness to healthcare AI, while doctors and pharmacists remain key trusted contacts.
Besins acquires UniD to expand pharmatech capabilities
Besins Healthcare acquires Belgium-based UniD Manufacturing to expand long-acting drug delivery and hormone health innovation capabilities.
Holger Holakovsky takes the lead in Dortmund
Holger Holakovsky has taken over the lead at Boehringer Ingelheim microParts in Dortmund as Simone Schulz moves to a global role.
NOWEDA: Udo Harneit to succeed Dr. Michael Kuck
NOWEDA CEO Dr. Michael Kuck will retire at the end of 2026. Sales board member Udo Harneit is set to take over in January 2027.
Vertex to buy Crinetics for about $10 billion
Vertex will acquire Crinetics for about $10 billion, adding PALSONIFY and late-stage endocrine disease assets to its portfolio.
Tatjana Dreyer takes communications role at Novartis Germany
Tatjana Dreyer has joined Novartis Germany to lead communications and patient advocacy, adding the role to the Country Leadership Team.